Ikarian Capital, LLC 13D/13G Filings for Avenue Therapeutics, Inc. (ATXI)

Ikarian Capital, LLC 13D and 13G filings for Avenue Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-02-17
5:09 pm
Sale
2025-12-3113GAVENUE THERAPEUTICS INC PA
ATXI
Ikarian Capital, LLC130,820
4.100%
-9,180decrease
(-6.56%)
Filing
2025-02-14
1:25 pm
Purchase
2024-12-3113GAVENUE THERAPEUTICS INC PA
ATXI
Ikarian Capital, LLC140,000
6.800%
140,000increase
(New Position)
Filing